Medical treatment of advanced testicular cancer.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2008-02-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jama.299.6.672PMID 18270356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Organization for Research and Treatment of Cancer

  2010cited by this paper
• Noncancer causes of death in survivors of testicular cancer.

  2007cited by this paper
• Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).

  2007cited by this paper
• Rational selection of patients for antibacterial prophylaxis after chemotherapy.

  2007cited by this paper
• Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.

  2007cited by this paper
• Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

  2007cited by this paper
• Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.

  2007cited by this paper
• High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.

  2007influential reference
• Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.

  2007cited by this paper
• Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.

  2007cited by this paper
• Mortality and incidence of second cancers following treatment for testicular cancer

  2007cited by this paper
• Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

  2007cited by this paper
• Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers.

  2007cited by this paper
• Retinal ischemia with neovascularization in cisplatin related retinal toxicity.

  2006cited by this paper
• Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.

  2006cited by this paper
• Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure

  2006cited by this paper
• Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer

  2006cited by this paper
• Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients.

  2006cited by this paper
• The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

  2006cited by this paper
• Extensive deep vein thrombosis as a complication of testicular cancer treated with the BEP protocol (bleomycin, etoposide and cisplatin): case report

  2006cited by this paper
• Late recurrences of germ cell malignancies: a population-based experience over three decades

  2006cited by this paper
• Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.

  2006cited by this paper
• Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.

  2006influential reference
• Late relapses of germ cell malignancies: incidence, management, and prognosis.

  2006cited by this paper
• Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors.

  2006cited by this paper
• Components of the metabolic syndrome in long-term survivors of testicular cancer.

  2006cited by this paper
• Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.

  2006influential reference
• Controversies in the management of clinical stage I testis cancer.

  2006cited by this paper
• Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis.

  2005cited by this paper
• Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer.

  2005cited by this paper
• Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults.

  2005cited by this paper
• Fertility, gonadal and sexual function in survivors of testicular cancer

  2005cited by this paper
• A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.

  2005cited by this paper
• Study of anxiety disorder and depression in long-term survivors of testicular cancer.

  2005cited by this paper
• UROLOGICAL ONCOLOGY: TESTIS CANCER AND ADVANCES IN ONCOLOGICAL THERAPY Gene Expression Profiling of Early- and Late-Relapse Nonseminomatous Germ Cell Tumor and Primitive Neuroectodermal Tumor of the Testis

  2005cited by this paper
• KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.

  2005cited by this paper
• Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.

  2005cited by this paper
• Role of Postchemotherapy Surgery in the Management of Patients With Liver Metastases From Germ Cell Tumors

  2005cited by this paper
• Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.

  2005cited by this paper
• Blood pressure and body mass index in long-term survivors of testicular cancer.

  2005cited by this paper
• Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.

  2005cited by this paper
• Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.

  2005cited by this paper
• Serum creatinine and cholesterol levels of testicular cancer patients in long‐term follow up

  2005cited by this paper
• Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.

  2005cited by this paper
• Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer.

  2005cited by this paper
• Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.

  2005cited by this paper
• Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.

  2005influential reference
• Paternity following treatment for testicular cancer.

  2005cited by this paper
• Acute arterial occlusion after chemotherapy for testicular cancer.

  2005cited by this paper
• Management of patients with low-stage nonseminomatous germ cell testicular cancer

  2005cited by this paper
• Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

  2004cited by this paper
• Mortality after cure of testicular seminoma.

  2004cited by this paper
• Late relapse of testicular cancer

  2004cited by this paper
• C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

  2004cited by this paper
• 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.

  2004cited by this paper
• Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.

  2004cited by this paper
• Tissue plasminogen activator antigen and coronary heart disease Prospective study and meta-analysis

  2004cited by this paper
• Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer.

  2004cited by this paper
• Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience

  2004cited by this paper
• Fertility after testicular cancer treatments

  2004cited by this paper
• Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

  2004cited by this paper
• Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.

  2004cited by this paper
• Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials

  2004cited by this paper
• Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

  2004influential reference
• The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours

  2003cited by this paper
• Long-Term Medical Care of Testicular Cancer Survivors

  2003cited by this paper
• Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer

  2003cited by this paper
• Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors.

  2003cited by this paper
• Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.

  2003cited by this paper
• Fertility in men with testicular germ cell tumors.

  2003cited by this paper
• Update on late relapse of germ cell tumor: a clinical and molecular analysis.

  2003cited by this paper
• "Onco-tese": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines?

  2003cited by this paper
• Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.

  2003cited by this paper
• Long-term survivors of testicular cancer.

  2003cited by this paper
• Cardiovascular disease as a long-term complication of treatment for testicular cancer.

  2003cited by this paper
• Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours.

  2003cited by this paper
• Alterations of the c‐kit gene in testicular germ cell tumors

  2003cited by this paper
• Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?

  2003cited by this paper
• Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors

  2003cited by this paper
• High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis.

  2002cited by this paper
• Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

  2002cited by this paper
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.

  2002cited by this paper
• Long-term renal function after treatment for malignant germ-cell tumours.

  2002cited by this paper
• Late recurrence in 1263 men with testicular germ cell tumors

  2002cited by this paper
• Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection.

  2002cited by this paper
• Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.

  2002cited by this paper
• Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

  2001cited by this paper
• The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors

  2001cited by this paper
• Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy

  2001cited by this paper
• Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

  2001cited by this paper
• Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

  2001cited by this paper
• Arterial occlusive events during chemotherapy for germ cell cancer.

  2001cited by this paper
• CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS

  2000cited by this paper
• Early Myocardial Infarction during Chemotherapy for Testicular Cancer

  2000cited by this paper
• A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma

  2000cited by this paper
• Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers.

  2000cited by this paper

• NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.

  2025cites this paper
• Diagnostic Accuracy of Ultrasound in Differentiating Benign and Malignant Testicular Tumors Using Computed Tomography as the Gold Standard

  2025cites this paper
• The management of testis cancer

  2025cites this paper
• The Role of HALP Score and Other Inflammatory Indices in Risk Stratification for Testicular Germ Cell Tumors

  2025cites this paper
• Tumores germinales

  2025cites this paper
• Precision Medicine in Thoracic Surgery: Chest Wall, Pleural, and Mediastinal Malignancies.

  2025cites this paper
• Cracking the Resistance Code:The Molecular Reclassification of Cancer and Precision Therapy Strategies.

  2025cites this paper
• Bilateral Seminoma in a Pediatric Patient With a History of Cryptorchidism: A Case Report

  2025cites this paper
• Commentary on "Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality".

  2025cites this paper
• Testicular cancer malpractice trends.

  2024cites this paper
• Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages.

  2024cites this paper
• Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system

  2024cites this paper
• Contemporary Role of Radiation Therapy in Testicular Cancer.

  2024cites this paper
• Treatment of a patient with disseminated testicular germ cell tumor associated with terminal chronic kidney disease requiring hemodialysis

  2024cites this paper
• Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumors

  2024cites this paper
• MicroRNA-320a enhances LRWD1 expression through the AGO2/FXR1-dependent pathway to affect cell behaviors and the oxidative stress response in human testicular embryonic carcinoma cells

  2024cites this paper
• Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy

  2024cites this paper
• Recent Advancements in Management for Non-Colorectal, Non-Neuroendocrine Hepatic Metastases.

  2024cites this paper
• Beta-catenin Alterations in Post-Chemotherapy Yolk Sac Tumor, Postpubertal-Type with Enteroblastic Features.

  2024cites this paper
• Chemomobilisation Using Gemcitabine-Oxaliplatin for Salvage High Dose Chemotherapy and Autologous Stem Cell Transplant in Advanced Testicular Germ Cell Cancer.

  2024cites this paper
• Nanostructured mesoporous silica carriers for platinum-based conjugates with anti-inflammatory agents.

  2024cites this paper
• Spinal Metastases in Non-Seminomatous Germ Cell Testicular Tumors: Prognosis and Integrated Therapeutic Approaches—A Systematic Review with an Institutional Case Illustration

  2024cites this paper
• Trends in genitourinary cancer mortality in the United States: analysis of the CDC-WONDER database 1999–2020

  2024cites this paper
• New insights on testicular cancer prevalence with novel diagnostic biomarkers and therapeutic approaches

  2024cites this paper
• Εmerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors.

  2023cites this paper
• Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study

  2023cites this paper
• Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio – conundrum or solution?

  2023cites this paper
• Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms

  2023cites this paper
• Long-term Cancer Survival Trends by Updated Summary Stage.

  2023cites this paper
• Predictors of Testicular Cancer Mortality in Brazil: A 20-Year Ecological Study

  2023cites this paper
• Molecular Biology of Pediatric and Adult Ovarian Germ Cell Tumors: A Review

  2023cites this paper
• Human organoid systems in modeling reproductive tissue development, function, and disease.

  2023cites this paper
• Testicular cancer in 2023: Current status and recent progress

  2023cites this paper
• Langetermijneffecten van de behandeling van patiënten met testiskanker: implicaties voor nazorg en follow-up

  2023cites this paper
• Effective and Selective Ru(II)-Arene Complexes Containing 4,4′-Substituted 2,2′ Bipyridine Ligands Targeting Human Urinary Bladder Cancer Cells

  2023cites this paper
• Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.

  2022cites this paper
• The management of testis cancer

  2022cites this paper
• The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit.

  2022cites this paper
• Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review

  2022influential citation
• Efficacy of Gemcitabine, Paclitaxel, and Oxaliplatin Protocol in the Treatment of Relapsed or Refractory Germ Cell Tumours.

  2022cites this paper
• Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.

  2022cites this paper
• RANKL regulates testicular cancer growth and Denosumab treatment has suppressive effects on GCNIS and advanced seminoma

  2022cites this paper
• Copper in the tumor microenvironment and tumor metastasis

  2022cites this paper
• Late ECG Changes after Cisplatin-Based Chemotherapy in Testicular Cancer Survivors

  2022cites this paper
• NPS-1034 Induce Cell Death with Suppression of TNFR1/NF-κB Signaling in Testicular Cancer

  2022cites this paper
• Cisplatin and Its Intercellular Cytotoxicity: Mechanism Derived from Different Pathway and Progression Targeting Toxicity Concern

  2022cites this paper
• Bone marrow metastasis in a patient with non‐seminomatous testicular germ cell tumor

  2022cites this paper
• Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases

  2022cites this paper
• Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry

  2022cites this paper
• Synchronous Testicular Cancer in Monozygotic Twins

  2022cites this paper
• An Update on Diagnostic Tissue-Based Biomarkers in Testicular Tumors.

  2022cites this paper
• GRP78/BiP determines senescence evasion cell fate after cisplatin-based chemotherapy

  2021cites this paper
• Editorial by Bendu K. Konneh, John T. Lafin and Aditya Bagrodia on pp. 341–342 of this issue

  2021cites this paper
• Successful “on‐demand” plerixafor for autologous peripheral blood stem‐cells transplantation for relapsed/refractory germ cell tumors

  2021cites this paper
• Recent advances in testicular germ cell tumours

  2021cites this paper
• Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment

  2021cites this paper
• Oncological outcomes of testicular cancer patients: 10 years of experiences resulting from a single university-based hospital

  2021cites this paper
• Testicular Cancer Radiotherapy

  2021cites this paper
• Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation

  2021cites this paper
• Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach.

  2021cites this paper
• Platinum Complexes in Colorectal Cancer and Other Solid Tumors

  2021cites this paper
• Current Management of Refractory Germ Cell Tumors

  2021cites this paper
• Visible haematuria—an unusual presentation of metastatic testicular mixed germ cell tumour

  2021cites this paper
• Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress

  2021cites this paper
• Contribution of Apaf-1 to the pathogenesis of cancer and neurodegenerative diseases.

  2021cites this paper
• Assessment of Resectability of Mediastinal Germ Cell Tumor Using Preoperative Computed Tomography.

  2021cites this paper
• Links between cancer metabolism and cisplatin resistance.

  2020cites this paper
• Considerations When Treating Patients with Good-risk Germ Cell Tumors.

  2020cites this paper
• A Case of Choriocarcinoma with Lung Metastasis as the First Symptom

  2020cites this paper
• Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.

  2020cites this paper
• Evaluation of nuclear NF-κB, transglutaminase2, and ERCC1 as predictors of platinum resistance in testicular tumors

  2020cites this paper
• Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell Tumors

  2020cites this paper
• Cancer, Testicular

  2020cites this paper
• Use of antioxidant could ameliorate the negative impact of etoposide on human sperm DNA during chemotherapy.

  2020cites this paper
• Dose‐dense chemotherapy for untreated poor‐prognosis and relapsed germ‐cell tumours: an 18‐year experience with GAMEC chemotherapy

  2020cites this paper
• Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era

  2020cites this paper
• Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment.

  2020cites this paper
• Differential gene expression in cisplatin-resistant and -sensitive testicular germ cell tumor cell lines

  2020cites this paper
• Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor

  2020cites this paper
• Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.

  2020cites this paper
• Sempervirine inhibits RNA polymerase I transcription independently from p53 in tumor cells

  2020cites this paper
• Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation

  2020cites this paper
• Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle.

  2020cites this paper
• 18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters

  2020cites this paper
• Thoracic Metastasectomy in Germ Cell Tumor Patients Treated with First-Line Versus Salvage.

  2020cites this paper
• Kiemceltumoren van de testis

  2020cites this paper
• DNA damage measured in blood cells predicts overall and progression-free survival in germ cell tumour patients.

  2020cites this paper
• Incidentally discovered primary mediastinal germ cell tumor.

  2020cites this paper
• Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours

  2020cites this paper
• Chemotherapy Curability in Leukemia, Lymphoma, Germ Cell Tumors and Gestational Malignancies: A Reflection of the Unique Physiology of Their Cells of Origin

  2020cites this paper
• Thromboembolic events after high‐intensity training during cisplatin‐based chemotherapy for testicular cancer: Case reports and review of the literature

  2020cites this paper
• Cachexia (Wasting Syndrome)

  2020cites this paper
• Multimodality Radiological Pictorial Review of Testicular Carcinoma: From Initial Staging to Restaging

  2020cites this paper
• Stereotactic Ablative Radiotherapy (SAbR) in the Setting of Metastatic Nonseminomatous Germ Cell Tumor of Testis.

  2019cites this paper
• High‐Dose Chemotherapy in Relapsed or Refractory Metastatic Germ‐Cell Cancer: The Scotland Experience

  2019cites this paper
• Paclitaxel, Iphospamide, and Cisplatin (TIP) as Bleomycin, Etoposide, and Cisplatin (BEP) Alternative for First-Line Therapy of Metastatic Germ Cell Tumor (GCT): A Case Series

  2019cites this paper
• Ag+ Complexes as Potential Therapeutic Agents in Medicine and Pharmacy.

  2019cites this paper
• Genetic and epigenetic modifications induced by chemotherapeutic drugs: human amniotic fluid stem cells as an in-vitro model

  2019cites this paper
• Case 14-2019: A 44-Year-Old Man with Neck Pain and Swelling.

  2019cites this paper
• Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines

  2019cites this paper